Forus Secures $160M Funding From Thrive Capital General Catalyst Accel Bain Capital Ventures Redpoint Ventures BoxGroup Pear VC

Forus, formerly known as Tandem, raised over $160 million in a funding round to enhance its AI-powered network that connects doctors, pharmacies, payers, and biopharma. The fundraising was backed by prominent investors including Thrive Capital, General Catalyst, Accel, Bain Capital Ventures, Redpoint Ventures, BoxGroup, and Pear VC.

Summary of transaction details:

• Deal Type: Funding
• Transaction Amount: $160,000,000
• Headquarters: New York City
• Founder: Sahir Jaggi
• Notable Investors: Thrive Capital, General Catalyst, Accel, Bain Capital Ventures, Redpoint Ventures, BoxGroup, Pear VC

The company's platform integrates into physician workflows, automating the processes between clinical decisions and the initiation of patient treatments. This includes functionalities such as insurance authorization, financial assistance, and fulfillment routing, effectively supporting every drug, payer, and pharmacy across the U.S. The platform is currently utilized by healthcare providers in all 50 states.